PH17820A - Pure crystalline 1,1-dioxo-penicillanoyloxymethyl 6-(d-alpha-amino-phenylacetamido)penicillanate tosylate salts,compositions containing same and method of use thereof - Google Patents

Pure crystalline 1,1-dioxo-penicillanoyloxymethyl 6-(d-alpha-amino-phenylacetamido)penicillanate tosylate salts,compositions containing same and method of use thereof

Info

Publication number
PH17820A
PH17820A PH26362A PH26362A PH17820A PH 17820 A PH17820 A PH 17820A PH 26362 A PH26362 A PH 26362A PH 26362 A PH26362 A PH 26362A PH 17820 A PH17820 A PH 17820A
Authority
PH
Philippines
Prior art keywords
penicillanoyloxymethyl
penicillanate
phenylacetamido
dioxo
alpha
Prior art date
Application number
PH26362A
Other languages
English (en)
Inventor
Wagn Ole Godtfredsen
Welf Von Daehne
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of PH17820A publication Critical patent/PH17820A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH26362A 1980-10-31 1981-10-19 Pure crystalline 1,1-dioxo-penicillanoyloxymethyl 6-(d-alpha-amino-phenylacetamido)penicillanate tosylate salts,compositions containing same and method of use thereof PH17820A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8035156 1980-10-31

Publications (1)

Publication Number Publication Date
PH17820A true PH17820A (en) 1985-01-07

Family

ID=10517019

Family Applications (1)

Application Number Title Priority Date Filing Date
PH26362A PH17820A (en) 1980-10-31 1981-10-19 Pure crystalline 1,1-dioxo-penicillanoyloxymethyl 6-(d-alpha-amino-phenylacetamido)penicillanate tosylate salts,compositions containing same and method of use thereof

Country Status (26)

Country Link
US (1) US4831025A (he)
JP (1) JPS57126493A (he)
KR (1) KR870001982B1 (he)
AT (1) AT373893B (he)
AU (1) AU543870B2 (he)
BE (1) BE890938A (he)
CA (1) CA1180696A (he)
CH (1) CH647527A5 (he)
DE (1) DE3143219A1 (he)
DK (1) DK154219C (he)
ES (1) ES8206531A1 (he)
FI (1) FI813331L (he)
FR (1) FR2493322B1 (he)
GB (1) GB2114969B (he)
GR (1) GR75369B (he)
IE (1) IE51640B1 (he)
IL (1) IL64009A (he)
IT (1) IT1193735B (he)
LU (1) LU83727A1 (he)
NL (1) NL8104938A (he)
NO (1) NO813683L (he)
NZ (1) NZ198622A (he)
PH (1) PH17820A (he)
PT (1) PT73913B (he)
SE (1) SE452322B (he)
ZA (1) ZA817091B (he)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432987A (en) * 1982-04-23 1984-02-21 Pfizer Inc. Crystalline benzenesulfonate salts of sultamicillin
PH20068A (en) * 1982-12-06 1986-09-18 Pfizer Process and intermediates for sultamicillin and analogs
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
ES2161602B1 (es) * 1999-04-08 2003-02-16 Asturpharma S A Sintesis de 6-(d-alfa-(bencilidenaminofenilacetamido))penicilanato de 1,1-dioxopenicilanoiloximetilo y analogos. nuevos intermedios para la sintesis de sultamicilina.
US6632453B2 (en) 2000-02-24 2003-10-14 Advancis Pharmaceutical Corp. Ciprofoxacin-metronidazole antibiotic composition
US6667057B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Levofloxacin antibiotic product, use and formulation thereof
US6667042B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Fluroquinilone antibiotic product, use and formulation thereof
US7025989B2 (en) * 2000-02-24 2006-04-11 Advancis Pharmaceutical Corp. Multiple-delayed released antibiotic product, use and formulation thereof
US6663891B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Erythromyacin antibiotic product, use and formulation thereof
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US6623758B2 (en) 2000-02-24 2003-09-23 Advancis Pharmaceutical Corp. Cephalosporin-metronidazole antibiotic composition
WO2001062195A1 (en) * 2000-02-24 2001-08-30 Advancis Pharmaceutical Corporation Antibiotic and antifungal compositions
US6663890B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Metronidazole antibiotic product, use and formulation thereof
US6669948B2 (en) 2000-02-24 2003-12-30 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6627222B2 (en) 2000-02-24 2003-09-30 Advancis Pharmaceutical Corp. Amoxicillin-dicloxacillin antibiotic composition
US6730320B2 (en) 2000-02-24 2004-05-04 Advancis Pharmaceutical Corp. Tetracycline antibiotic product, use and formulation thereof
US6638532B2 (en) 2000-02-24 2003-10-28 Advancis Pharmaceutical Corp. Tetracycline—doxycycline antibiotic composition
US6610328B2 (en) 2000-02-24 2003-08-26 Advancis Pharmaceutical Corp. Amoxicillin-clarithromycin antibiotic composition
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
EP1257255A4 (en) * 2000-02-24 2008-07-30 Advancis Pharmaceutical Corp THERAPEUTIC PRODUCT, ITS USE AND MANUFACTURE
US7105174B2 (en) * 2000-10-13 2006-09-12 Advancis Pharmaceutical Corporation Multiple-delayed release anti-neoplastic product, use and formulation thereof
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
US7157095B2 (en) * 2000-10-13 2007-01-02 Advancis Pharmaceutical Corporation Multiple-delayed release antifungal product, use and formulation thereof
US20020197314A1 (en) 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US20040114368A1 (en) * 2002-12-13 2004-06-17 Shyu Shing Jy Light device having rotatable or movable view
US20040265323A1 (en) * 2003-05-16 2004-12-30 Mccormick Beth A. Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin A3), inhibitors thereof and methods of use thereof
AU2004258944B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2007502296A (ja) 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
WO2005023184A2 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2006014427A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
WO2007004239A1 (en) * 2005-07-06 2007-01-11 Morepen Laboratories Limited New polymorphic form of sultamicillin tosylate and a process therefor
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
PL2874624T3 (pl) 2012-07-17 2020-07-27 Bayer New Zealand Limited 3 Argus Place Hillcrest, Auckland 0627 / NZ Wstrzykiwalne formulacje antybiotykowe i sposoby ich zastosowania
EP2874623B1 (en) 2012-07-17 2018-12-12 Bayer New Zealand Limited Injectable antibiotic formulations and their methods of use
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1532222A (fr) * 1963-10-28 1968-07-12 Bristol Myers Co Procédé de préparation de dérivés de la pénicilline
KR830001903B1 (ko) * 1979-02-13 1983-09-19 레오 파마슈티칼 프로덕츠 리미티드 페니실란산유도체의 제조방법
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate

Also Published As

Publication number Publication date
GR75369B (he) 1984-07-13
IT1193735B (it) 1988-08-24
PT73913B (en) 1984-05-29
IE812361L (en) 1982-04-30
NL8104938A (nl) 1982-05-17
FR2493322B1 (fr) 1986-06-13
KR870001982B1 (ko) 1987-10-24
IT8168383A0 (it) 1981-10-23
GB2114969B (en) 1985-02-20
DK472181A (da) 1982-05-01
LU83727A1 (fr) 1982-05-07
ES506751A0 (es) 1982-08-16
IL64009A (en) 1984-09-30
DK154219B (da) 1988-10-24
PT73913A (en) 1981-11-01
SE8106404L (sv) 1982-05-01
CA1180696A (en) 1985-01-08
NZ198622A (en) 1985-07-12
KR830007671A (ko) 1983-11-04
US4831025A (en) 1989-05-16
SE452322B (sv) 1987-11-23
AU7636581A (en) 1982-05-06
FR2493322A1 (fr) 1982-05-07
IL64009A0 (en) 1982-01-31
JPS57126493A (en) 1982-08-06
ATA447781A (de) 1983-07-15
DE3143219A1 (de) 1982-08-12
GB2114969A (en) 1983-09-01
AU543870B2 (en) 1985-05-09
DE3143219C2 (he) 1990-05-17
ES8206531A1 (es) 1982-08-16
CH647527A5 (de) 1985-01-31
AT373893B (de) 1984-02-27
IE51640B1 (en) 1987-01-21
DK154219C (da) 1989-03-20
NO813683L (no) 1982-05-03
ZA817091B (en) 1982-10-27
JPH027957B2 (he) 1990-02-21
FI813331L (fi) 1982-05-01
BE890938A (fr) 1982-04-30

Similar Documents

Publication Publication Date Title
PH17820A (en) Pure crystalline 1,1-dioxo-penicillanoyloxymethyl 6-(d-alpha-amino-phenylacetamido)penicillanate tosylate salts,compositions containing same and method of use thereof
IL63839A0 (en) N-arylbenzamides,herbicidal compositions containing them and method of using them
ZA82158B (en) New furo-(3,4-c)-pyridine derivatives, process of preparation of the same and therapeutical composition containing the same
PH18959A (en) Novel cephalosporin compounds,compositions containing same and method of use thereof
PH18392A (en) Novel quinolone compounds,compositions containing same and method of use thereof
GB2091257B (en) Process composition and concentrate for preparing substituted urea derivatives
PH14401A (en) Hydroxyaminohydrocarbonphosphonic acid derivatives,compositions containing same and method of use
PH19244A (en) Novel lactobacillus,composition containing same and method of use thereof
PH14356A (en) Derivatives of penicillanic acid,compositions containing same and method of use
IL82378A0 (en) Sulfonamides,method of producing same and herbicidal compositions containing them
PT75489A (en) Process for preparing pyridine and pyrazine derivatives and of fungicidal compositions containing the same
PH19005A (en) Penicillanic acid derivatives,pharmaceutical compositions containing the same and method of use thereof
PH19352A (en) Fluoromethylthiooxacephalosporins derivatives compositions containing same and method of use thereof
PH20406A (en) Substituted acylamino-s-triazines,pesticidal compositions containing same and method of use thereof
PT79323A (en) Process for the manufacture of pyridine pyrazine and pyrimidine derivatives and of fungicidal compositions containing the same
HUT35653A (en) Process for preparing barbituric acid derivatives and anthelmintic compositions containing such compounds
PH21556A (en) Phenyl nonatetraenoic acid derivatives, pharmaceutical compositions containing the same and method of use thereof
PT81501A (en) Process for producing heterocyclic compounds and of herbicidal compositions containing such compounds
PH17057A (en) Kijanimicin and salts thereof,pharmaceutical compositions containing same and process of preparring same
PH20385A (en) Ergot alkaloids, compositions containing the same and method of use thereof
DE3175599D1 (en) Method of making certain 2,3-or 5,6-dihydro-1,4-dithiins
EP0127371A3 (en) 1,n-diaryl-4,5-dihydro-1h-pyrazol-3-amines, compositions containing them and methods for their preparation
IL62996A0 (en) Hexahydroisoindole derivatives process for their preparation and herbicidal compositions containing them
PH19991A (en) Composition containing carbazic acid derivatives and of use thereof
DE3161847D1 (en) Cyclic esters, process for their preparation and their use as parfuming and flavouring agents; parfume and flavouring compositions containing them

Legal Events

Date Code Title Description
AT Record of annual fee payments

Year of fee payment: 12